Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Neoplasms × Vertebroplasty × Clear all

Phase

Phase NA 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Spinal Diseases 1 Neoplasms 1

Interventions

Dexamethasone 8 Oxycodone 6 Epoetin Alfa 5 Propofol 4 Palonosetron 4 Zoledronic Acid 3 Sevoflurane 3 Ondansetron 3 Naloxone 3 Meropenem 3 Everolimus 3 Cholecalciferol 3 Calcium Dobesilate 3 Bevacizumab 3 Aspirin 3 Aprepitant 3 peginterferon alfa-2a 2 edoxaban 2 apixaban 2 apatinib 2 Vitamin B 12 2 Vincristine 2 Vancomycin 2 Tobacco Use Cessation Devices 2 Tablets 2 Surgical Procedures, Operative 2 Sodium Chloride 2 Saline Solution 2 Rivaroxaban 2 Rituximab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00819832 2023-03-24

Anderson Circulating Tumor Cell Burden (CTCB) Study

M.D. Anderson Cancer Center

Phase 4 Terminated

3 enrolled 2 charts

Neoplasms, Spinal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡